Physician profile
Jason A Davis
NPI 1912095076
$8,836.73
in general payments reported to CMS, 2019-2025
13 companies · $901 in 2025
The $901 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $423 · 2020: $5,162 · 2021: $478 · 2022: $464 · 2023: $1,140 · 2024: $270 · 2025: $901.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,645 · Travel and Lodging: $468 · Education: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,645.00 |
| Travel and Lodging | $468.16 |
| Education | $196.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,670.46 | 2020-2023 | |
| Pylant Medical | $824.20 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $767.77 | 2019-2025 | Oxford, Persona, Gps III Platelet Concentration System |
| Depuy Synthes Sales INC. | $492.41 | 2021-2025 | Na, Orthovisc, Monovisc |
| Smith+Nephew, INC. | $429.82 | 2019-2022 | |
| Stryker Corporation | $324.64 | 2021-2025 | Gamma |
| Cumberland Pharmaceuticals, INC. | $85.76 | 2022-2023 | Caldolor |
| Orthofix Medical, INC. | $63.70 | 2025 | Physio-Stim |
| Bioventus LLC | $50.96 | 2024-2025 | Durolane |
| Acumed LLC | $41.36 | 2023 | Acumed |
| Horizon Therapeutics Plc | $40.37 | 2020-2021 | |
| Vericel Corporation | $24.84 | 2024 | Maci |
| Pacira Therapeutics, INC. | $20.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.